AfroCentric divests Activo Health to FHC Group as it refocuses on health services and administration in a major portfolio shift.

Global malaria crisis worsens as US aid cuts, rising resistance, and stalled progress put millions, especially children, at deadly risk.

Dis-Chem’s personalised healthcare model uses AI and data to offer tailored care, rewards, and insurance – reshaping retail pharmacy.

Aspen APAC divestment unlocks R26.5bn in capital, sharpening the group’s focus on GLP-1 injectables and reducing net debt heading into 2026.

GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.

America First health funding plan faces legal challenges in Kenya over privacy, even as Uganda secures $1.7B with new co-financing model.

As the medical tax credits debate intensifies, experts warn that scrapping them could destabilise South Africa’s healthcare system.

Motsoaledi defends NHI, rejecting claims of judicial bias and backing the scheme as key to universal health coverage.

HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.

Spar Wellness Pharmacy Expansion taps into growing consumer demand for health and wellness, aiming to challenge Clicks and Dis-Chem.

SA’s healthcare austerity crisis erodes specialist training and public health capacity, risking rights to care and driving emigration.